Session IV: Dyslipidemia/Atherosclerosis/Thrombosis

Emerging Therapies in Dyslipidemia: Spotlight on CETP Inhibitors

Speaker(s)

• 

  Erin D. Michos, MD, MHS (she/her/hers)

  Director of Women's Cardiovascular Health
  Johns Hopkins University School of Medicine
  Johns Hopkins University School of Medicine
  Baltimore, Maryland, United States
• 

  Christie M. Ballantyne, MD (he/him/his)

  Professor of Medicine
  Baylor College of Medicine
  Baylor College of Medicine
  Houston, Texas, United States